Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Microbix Biosystems buys ImaRx's urokinase business

Executive Summary

ImaRx Therapeutics (cardiovascular drugs) has agreed to sell its Kinlytic urokinase business to Microbix Biosystems (developing vaccines).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Intra-Biotech Deal
    • Includes Earnout
    • Full Acquisition
    • Payment Includes Cash
    • Includes Contract

Related Companies